Managing mitral valve disease in dogs
In this interview, faculty member Dr Natalie Marks shares how GPs can use diagnostics and collaborate with clients for the best outcomes
In this dvm360® interview, Fetch Charlotte faculty member Natalie Marks, DVM, CVJ, describes the key role the general practitioner can play when confronted with canine mitral valve disease.
The following is a partial transcript of the video.
Natalie Marks, DVM, CVJ: We have a big part in educating our clients appropriately and also learning about the latest and greatest new techniques and treatments, according to those cardiovascular guidelines that have been put together by experts in the field, so that we're really making sure to do the best that we can, again from that very first visit, that very first discussion and knowing that we play a huge role in the success of that patient.
Veterinary Heroes: Ann E. Hohenhaus, DVM, DACVIM (Oncology, SAIM)
December 1st 2024A trailblazer in small animal internal medicine, Ann E. Hohenhaus, DVM, DACVIM (Oncology, SAIM), has spent decades advancing the profession through clinical expertise, mentorship, and impactful communication.
Read More
Oral solution approved by the FDA for canine heart failure
November 22nd 2024Vetmedin Solution from Boehringer Ingelheim is indicated for treatment of cases caused by myxomatous mitral valve disease or dilated cardiomyopathy and is the first oral solution approved by the FDA for this use in dogs
Read More
